About Asia Cuanon Technology (Shanghai) Co.Ltd(603378) Technology (Shanghai) Co., Ltd
Reply to the inquiry letter on matters related to abnormal fluctuations in stock trading Asia Cuanon Technology (Shanghai) Co.Ltd(603378) Technology (Shanghai) Co., Ltd.:
We have received the inquiry letter on matters related to abnormal fluctuations in stock trading of Asia Cuanon Technology (Shanghai) Co.Ltd(603378) Technology (Shanghai) Co., Ltd. from your company. After careful self-examination and verification, we hereby reply to the relevant matters as follows:
As the controlling shareholder of Asia Cuanon Technology (Shanghai) Co.Ltd(603378) Technology (Shanghai) Co., Ltd. (hereinafter referred to as ” Asia Cuanon Technology (Shanghai) Co.Ltd(603378) “), up to now, the company has no major information that should be disclosed but not disclosed, including but not limited to major asset restructuring, issuance of shares, acquisition of listed companies, debt restructuring, business restructuring, asset stripping, asset injection, share repurchase, equity incentive, bankruptcy reorganization Major business cooperation, introduction of strategic investors and other major issues.
We hereby reply.
Shanghai Chuangming Investment Co., Ltd. February 8, 2022
About Asia Cuanon Technology (Shanghai) Co.Ltd(603378) Technology (Shanghai) Co., Ltd
Reply to the inquiry letter on matters related to abnormal fluctuations in stock trading Asia Cuanon Technology (Shanghai) Co.Ltd(603378) Technology (Shanghai) Co., Ltd.:
We have received the inquiry letter on matters related to abnormal fluctuations in stock trading of Asia Cuanon Technology (Shanghai) Co.Ltd(603378) Technology (Shanghai) Co., Ltd. from your company. After careful self-examination and verification, we hereby reply to the relevant matters as follows:
As the actual controller of Asia Cuanon Technology (Shanghai) Co.Ltd(603378) Technology (Shanghai) Co., Ltd. (hereinafter referred to as ” Asia Cuanon Technology (Shanghai) Co.Ltd(603378) “), up to now, I have no major information that should be disclosed but not disclosed, including but not limited to major asset restructuring, issuance of shares, acquisition of listed companies, debt restructuring, business restructuring, asset stripping, asset injection, share repurchase, equity incentive, bankruptcy reorganization Major business cooperation, introduction of strategic investors and other major issues.
We hereby reply.
Li Jinzhong February 8, 2022
